Opportunity Information: Apply for RFA GH 13 002

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
  • This funding opportunity was created on Dec 20, 2012 and posted on Dec 20, 2012.
  • Applicants must submit their applications by Mar 20, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $1,900,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $9,000,000.00 in funding.
  • The number of recipients for this funding is limited to 7 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) Eligible Agencies of the Federal Government Other Foreign Organizations a Foreign Organization is a public or private organization, whether non profit or for profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance.
Apply for RFA GH 13 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The CDC grant opportunity titled "Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa" (Funding Opportunity Number RFA GH 13 002) was a discretionary health funding announcement designed to build practical, on-the-ground partnerships that improve how neglected tropical disease (NTD) programs are tracked, assessed, and improved. Although the title emphasizes Africa, the announcement makes clear that CDC sought collaborators working in relevant settings across Africa, Asia, and the Americas. The central idea is that NTD control and elimination programs depend on reliable monitoring and evaluation, and CDC wanted partners who could help strengthen both the tools and the real-world use of those tools so programs can better demonstrate impact, detect gaps, and make timely course corrections.

The purpose of the cooperative agreement was threefold. First, CDC aimed to promote and strengthen NTD control and elimination efforts, meaning the work was expected to support the performance and effectiveness of public health programs targeting neglected tropical diseases rather than purely academic research in isolation. Second, the opportunity focused on improving monitoring and evaluation (M&E) tools used to measure program impact and performance in international NTD programs. In practice, this can include improving indicators, data collection approaches, survey methods, supervisory tools, data quality procedures, and analytical frameworks that help programs answer basic questions like whether interventions are reaching intended populations, whether disease burden is declining, and whether implementation quality is improving over time. Third, CDC wanted partners to help determine the best ways to use both existing and newly developed M&E tools to measure outcomes in single-disease programs as well as integrated NTD programs, reflecting the reality that many countries bundle multiple NTD interventions together and need evaluation approaches that work across diseases and delivery platforms.

The funding instrument was a cooperative agreement, which typically signals a substantial level of scientific or programmatic involvement by CDC during the period of performance. Rather than simply issuing funds and stepping back, CDC’s intent was to work jointly with awardees in planning, implementing, and refining M&E approaches in the field. This structure aligns with the opportunity’s emphasis on collaboration and operational learning: partners would contribute technical expertise and local implementation capacity, while CDC would provide guidance, alignment with global standards, and support for translating findings into improved practice.

The announcement anticipated making up to 7 awards and listed an estimated total funding level of $1,900,000. It also provided an award ceiling of $9,000,000 and an award floor of $0, which is a way of stating the upper bound that could apply under certain circumstances, while also indicating that award sizes could vary depending on the final scope and availability of funds. There was no cost-sharing or matching requirement, lowering the barrier for organizations that might not have large unrestricted resources to contribute.

Eligibility was broad and intentionally inclusive to attract strong technical and field partners. Eligible applicants included higher education institutions (public/state-controlled and private), as well as institutions specifically encouraged to apply such as Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions. The opportunity also allowed applications from nonprofits (including those other than institutions of higher education), eligible federal agencies, and foreign organizations. The inclusion of foreign organizations is notable because it supports direct participation by organizations located outside the United States that are subject to the laws of their home countries, which can be important for locally led M&E strengthening in endemic settings.

Key administrative details place the opportunity in the 2012-2013 cycle. The posting date and creation date were December 20, 2012, and the application closing date was March 20, 2013, with the archive date listed as April 19, 2013. The CFDA number associated with the opportunity was 93.283, under CDC’s "Investigations and Technical Assistance" authority, which fits the applied public health and capacity-building orientation of M&E strengthening in international disease programs.

For applicants or interested parties who had trouble accessing the full announcement, CDC provided a contact through the CDC Procurement and Grants Office Technical Information Management, reachable by phone at (770) 488-2700 or by email at pgotim@cdc.gov. Overall, the opportunity was aimed at improving the quality, consistency, and usefulness of evidence generated by NTD programs, with the practical goal of helping countries and partners better measure progress toward control and elimination and make smarter program decisions based on stronger data.

Frequently Asked Questions (FAQs)

What is the title of this CDC grant opportunity?

The funding opportunity is titled "Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa."

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number is RFA GH 13 002.

What type of funding opportunity was this?

This was a CDC discretionary health funding announcement.

What was the main goal of this opportunity?

The main goal was to build practical, on-the-ground partnerships that strengthen monitoring and evaluation (M&E) for neglected tropical disease (NTD) control and elimination programs so those programs can better track performance, assess impact, identify gaps, and make timely improvements.

Was this opportunity limited only to Africa?

No. While the title emphasizes Africa, the announcement indicated CDC sought collaborators working in relevant settings across Africa, Asia, and the Americas.

What kind of work did CDC want to support through this cooperative agreement?

CDC aimed to support applied public health work that strengthens the performance and effectiveness of NTD control and elimination programs, with a focus on improving how programs are monitored and evaluated rather than conducting purely academic research in isolation.

What were the three main purposes of the cooperative agreement?

The cooperative agreement had three purposes: (1) promote and strengthen NTD control and elimination efforts; (2) improve M&E tools used to measure program impact and performance in international NTD programs; and (3) determine the best ways to use existing and newly developed M&E tools to measure outcomes in both single-disease and integrated NTD programs.

What does "monitoring and evaluation (M&E)" mean in the context of this opportunity?

In this context, M&E refers to the practical methods and tools programs use to track whether interventions are reaching intended populations, whether disease burden is declining, and whether implementation quality is improving over time, so program decisions can be based on reliable evidence.

What kinds of M&E tools or approaches were in scope?

The opportunity described improving indicators, data collection approaches, survey methods, supervisory tools, data quality procedures, and analytical frameworks used to measure program impact and performance.

Did CDC want applicants to focus on single diseases or multiple diseases?

Both. CDC wanted partners to help determine the best ways to use M&E tools for single-disease programs and for integrated NTD programs, recognizing that many countries bundle multiple NTD interventions together.

What was the funding instrument?

The funding instrument was a cooperative agreement.

What does it mean that this was a cooperative agreement?

A cooperative agreement typically involves substantial scientific or programmatic involvement by CDC during the period of performance. The intent described here was that CDC would work jointly with awardees to plan, implement, and refine M&E approaches in real-world settings.

How many awards did CDC anticipate making?

The announcement anticipated making up to 7 awards.

What was the estimated total funding for this opportunity?

The estimated total funding level listed was $1,900,000.

What were the award ceiling and award floor?

The announcement listed an award ceiling of $9,000,000 and an award floor of $0, indicating award sizes could vary depending on scope and availability of funds, with an upper bound that could apply under certain circumstances.

Was cost sharing or matching required?

No. The opportunity stated there was no cost-sharing or matching requirement.

Who was eligible to apply?

Eligibility was broad and included higher education institutions (public/state-controlled and private), nonprofits (including those other than institutions of higher education), eligible federal agencies, and foreign organizations.

Were any institution types specifically encouraged to apply?

Yes. The announcement specifically encouraged applications from Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions.

Could foreign organizations apply?

Yes. The opportunity allowed applications from foreign organizations, supporting participation by organizations located outside the United States and subject to the laws of their home countries.

What were the key dates for this funding opportunity?

The posting date and creation date were December 20, 2012. The application closing date was March 20, 2013. The archive date was April 19, 2013.

What CFDA number was associated with this opportunity?

The CFDA number associated with the opportunity was 93.283.

What CDC authority or program area was this tied to?

The CFDA listing referenced CDC's "Investigations and Technical Assistance" authority, which aligns with applied public health work and capacity-building to strengthen monitoring and evaluation for international NTD programs.

How could someone get help if they had trouble accessing the full announcement?

CDC provided a contact through the CDC Procurement and Grants Office Technical Information Management. They could be reached by phone at (770) 488-2700 or by email at pgotim@cdc.gov.

What was the practical intended impact of this opportunity?

The opportunity aimed to improve the quality, consistency, and usefulness of evidence generated by NTD programs so countries and partners can better measure progress toward control and elimination and make smarter program decisions based on stronger data.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Exemplar Health Information Exchange Governance Entities Program

Previous opportunity: AFRL Research Collaboration Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA GH 13 002

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA GH 13 002) also looked into and applied for these:

Funding Opportunity
Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001

Funding Number: HIEGE HG 12 001
Agency: Office of the National Coordinator
Category: Health
Funding Amount: $400,000
Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061

Funding Number: PAR 13 061
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213

Funding Number: HRSA 13 213
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $110,000
Limited Competition Initiative to Maximize Research Education in Genomics (R25) Diversity Action Plan Apply for PAR 13 063

Funding Number: PAR 13 063
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building healthcare practitioner capacity around HPV Vaccine Communication Apply for RFA IP 13 001

Funding Number: RFA IP 13 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 003

Funding Number: RFA GM 14 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $75,000
Telehealth Resource Center Grant Program Apply for HRSA 13 167

Funding Number: HRSA 13 167
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $325,000
Implementation Support for State Demonstrations to Integrate Care for Medicare Medicaid Enrollees Apply for CMS 1I1 13 001

Funding Number: CMS 1I1 13 001
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $15,000,000
Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 13 001

Funding Number: SP 13 001
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $50,000
The CDCs National Undergraduate Student Program A Public Health Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 1101

Funding Number: CDC RFA MN11 1101
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,850,000
FY 2013 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 13 002

Funding Number: SM 13 002
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $60,000
Planning Grants for Expansion of the Comprehensive Community Mental Health Services for Children and Their Families Apply for SM 13 001

Funding Number: SM 13 001
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $800,000
Support of Competitive Research (SCORE) Research Advancement Award (SC1) Apply for PAR 13 069

Funding Number: PAR 13 069
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Support of Competitive Research (SCORE) Pilot Project Award (SC2) Apply for PAR 13 070

Funding Number: PAR 13 070
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Support of Competitive Research (SCORE) Research Continuance Award (SC3) Apply for PAR 13 071

Funding Number: PAR 13 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $75,000
International Research Scientist Development Award (IRSDA) (K01) Apply for PAR 13 072

Funding Number: PAR 13 072
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Clinical Study Planning Grant Program (R34) Apply for PAR 13 073

Funding Number: PAR 13 073
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Functional Epigenomics Developing Tools and Technologies for Cell type, Temporal, or Locus specific Manipulation of the Epigenome (R01) Apply for RFA RM 12 026

Funding Number: RFA RM 12 026
Agency: National Institutes of Health
Category: Health
Funding Amount: $325,000
Human Immunodeficiency Virus (HIV) Prevention Projects for the Commonwealth of Puerto Rico and United States Virgin Islands Apply for CDC RFA PS13 1310

Funding Number: CDC RFA PS13 1310
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
Healthcare Management and Administration (HMA) Education Twinning in Mozambique Apply for RFA 656 13 000006

Funding Number: RFA 656 13 000006
Agency: Mozambique USAID Maputo
Category: Health
Funding Amount: $2,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 13 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.